Combinations for Prophylaxis and/or Treatment of Benign Prostatic Hyperplasia Containing a 17 Beta-hydroxy Steroid Dehydrogenase (17BHSD) Inhibitor and at Least One Further Active Ingredient

摘要

A therapeutic combination, useful in the treatment of benign prostatic hyperplasia, includes an inhibitor of 17 beta -hydroxysteroid dehydrogenase activity and at least one further active ingredient selected from the group comprising antiestrogens, inhibitors of 5 alpha -reductase activity and inhibitors of aromatase activity. Pharmaceutical compositions and kits useful for such treatment are also provided.